
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+11
Imugene is a clinical stage immuno-oncology company developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Our unique platform technologies seek to harness the bodys immune system against tumours, potentially achieving a similar or greater effect than synthetically manufactured monoclonal antibody and other immunotherapies. Our product pipeline includes multiple immunotherapy B-cell vaccine candidates and an oncolytic virotherapy (CF33) aimed at treating a variety of cancers in combination with standard of care drugs and emerging immunotherapies. We are supported by a leading team of international cancer experts...
Immuno-oncology,cancer vaccines,her-2+ cancers,mimotopes,pd-1,biotechnology,immunotherapy,biotech,immune system,cancer experts,b-cell peptide vaccines,b-cell,b-cell vaccine technology,cancer therapy,drug development,and immune checkpoint inhibitor monoclonal antibodies
Imugene limited operates in the Biotechnology research industry.
Imugene limited's revenue is 11m - 100m
Imugene limited has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.